| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |